PBLD Monoklonaler Antikörper
PBLD Monoklonal Antikörper für WB, IF/ICC, Indirect ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
Hausschwein, human
Anwendung
WB, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
1G11D4
Kat-Nr. : 68317-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
68317-1-PBS bindet in WB, IF/ICC, Indirect ELISA PBLD und zeigt Reaktivität mit Hausschwein, human
| Getestete Reaktivität | Hausschwein, human |
| Wirt / Isotyp | Maus / IgG1 |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | PBLD fusion protein Ag23827 |
| Vollständiger Name | phenazine biosynthesis-like protein domain containing |
| Beobachtetes Molekulargewicht | 30 kDa |
| GenBank-Zugangsnummer | BC009738 |
| Gene symbol | PBLD |
| Gene ID (NCBI) | 64081 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-G-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
PBLD, also termed as MAWBP, was first identified from a human liver cDNA library using a yeast two-hybrid technique by Iriyama et al. As the only representative of phenazine biosynthesis-like protein family, PBLD is widely expressed in human tissues, such as brain, heart, lung, liver, pancreas, kidney, and placenta. Its expression is elevated in several diseases processes, including insulin resistance, folate deficiency, and hypotension. PBLD has been proved to be involved in gastric carcinogenesis, PBLD expression was attenuated in gastric cancer (GC) tissues, and negatively regulated the growth and invasion in gastric cancer cell-lines by inhibiting TGF-β1-induced EMT (Epithelial-Mesenchymal Transition).(PMID: 11355021, 17929853, 23687415, 26594798)





